ABL Bio Market Cap

ABL Bio has a market cap or net worth of 1.67 trillion as of March 31, 2025. Its market cap has increased by 53.10% in one year.

Market Cap

1.67T

Enterprise Value

1.58T

Revenue

33.40B

Ranking

n/a

PE Ratio

n/a

Stock Price

34,450.00

Market Cap Chart

Since December 19, 2018, ABL Bio's market cap has increased from 608.61B to 1.67T, an increase of 174.69%. That is a compound annual growth rate of 17.44%.

Market Cap History

Date	Market Cap	% Change
Mar 31, 2025	1,671.79B	15.80%
Dec 30, 2024	1,443.63B	22.53%
Dec 28, 2023	1,178.16B	7.19%
Dec 29, 2022	1,099.13B	5.54%
Dec 30, 2021	1,041.42B	-27.59%
Dec 30, 2020	1,438.26B	31.46%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	74.66T
Celltrion	38.03T
ALTEOGEN	18.79T
Yuhan	8,537.79B
SK Biopharmaceuticals	7,893.98B
HLB Co., Ltd.	7,500.72B
Sam Chun Dang Pharm.	3,930.51B
PharmaResearch	3,506.51B

Market Cap Rankings